Literature Review on Traditional Chinese Medicine Interventions for Type 2 Diabetes Mellitus: Efficacy, Mechanisms, and Evidence Gaps

1.0 Introduction: The Growing Challenge of Type 2 Diabetes and the Need for Integrative Therapies

Type 2 Diabetes Mellitus (T2DM) represents one of the most significant and escalating public health challenges of the twenty-first century. The global burden is driven by a complex interplay of genetic, metabolic, and environmental factors, including modifiable lifestyle elements such as diet. For instance, in 2020 alone, an estimated 2.2 million new T2DM cases, representing 9.8% of all incident cases, were attributable to the consumption of sugar-sweetened beverages. This stark statistic underscores the profound impact of lifestyle on disease incidence. According to the International Diabetes Federation, approximately 589 million adults aged 20 to 78 years were living with diabetes globally in 2024, a figure projected to surge to 853 million by 2050. This growing burden imposes substantial economic strain on healthcare systems, leads to life-altering complications such as cardiovascular disease, nephropathy, and neuropathy, and significantly diminishes patients' quality of life. This context necessitates a rigorous exploration of all effective, safe, and accessible therapeutic strategies.

While modern pharmacological interventions are central to glycemic control, they are not without significant limitations. Common side effects associated with oral hypoglycemic agents and insulin therapy include hypoglycemia, gastrointestinal discomfort, weight gain, and genitourinary tract infections. Furthermore, complex medication regimens can lead to poor long-term adherence, and the high cost of newer drugs creates a substantial economic barrier for many patients and healthcare systems. These challenges underscore an urgent need for therapeutic approaches that can complement conventional care, mitigate side effects, and improve overall health outcomes.

Traditional Chinese Medicine (TCM), an ancient system of health and wellness, offers a promising field for complementary T2DM management. Its two main pillars—herbal medicine and traditional Chinese exercise (TCE)—are grounded in a holistic philosophy that aligns well with the multifactorial nature of T2DM. This review's objective is to provide a comprehensive, evidence-based analysis of the efficacy, underlying mechanisms, and current quality of evidence for these interventions. By systematically evaluating the existing literature, this review intends to inform current clinical practice and guide the direction of future research in integrative diabetes care. Understanding how these therapies may exert their effects requires a foundational knowledge of the complex pathophysiology of T2DM.

2.0 The Pathophysiology of Type 2 Diabetes Mellitus: A Modern Mechanistic Overview

A strategic understanding of the multifaceted pathophysiology of T2DM is essential for evaluating the potential of any therapeutic intervention. The disease is not merely a consequence of impaired glucose regulation but a complex interplay of systemic metabolic disturbances. This section outlines the key molecular and cellular mechanisms that drive T2DM, providing a scientific framework for assessing the multi-target nature of TCM interventions and understanding how they may modulate these pathological pathways.

The primary mechanisms contributing to T2DM pathogenesis include:

• Inflammation and Oxidative Stress: Chronic hyperglycemia promotes the non-enzymatic glycation of proteins and lipids, leading to the formation of Advanced Glycation End Products (AGEs). The accumulation of AGEs activates inflammatory pathways, such as the nuclear factor kappa B (NF-κB) signaling cascade, and increases the production of reactive oxygen species (ROS). This state of chronic, low-grade inflammation and oxidative stress directly impairs insulin signaling, damages pancreatic β-cells, and contributes to the development of diabetic complications.
• Insulin Resistance (IR): IR is a hallmark of T2DM, where target tissues like the liver, muscle, and adipose tissue become less responsive to insulin. Inflammatory signals and oxidative stress disrupt the insulin signaling cascade by interfering with the phosphorylation of key proteins like the Insulin Receptor Substrate (IRS). This disruption leads to reduced glucose uptake and utilization, forcing the pancreas to produce more insulin to maintain glycemic control, a state known as compensatory hyperinsulinemia.
• Pancreatic β-cell Dysfunction: Initially, pancreatic β-cells compensate for IR by increasing insulin production. However, prolonged exposure to high glucose levels (glucotoxicity), elevated free fatty acids (lipotoxicity), oxidative stress, and inflammatory cytokines leads to a progressive decline in β-cell function. This dysfunction manifests as reduced insulin synthesis and secretion and can ultimately lead to β-cell death (apoptosis), resulting in a relative insulin deficiency.
• Gut Microbiota Dysbiosis: The composition of the gut microbiota plays a crucial role in host metabolism. In T2DM, alterations in this microbial community, or dysbiosis, can contribute to the disease through several mechanisms. These include changes in the production of short-chain fatty acids (SCFAs), which influence hormone secretion and energy homeostasis; altered bile acid metabolism, which affects glucose and lipid regulation; and increased intestinal permeability, which can lead to higher levels of circulating endotoxins like lipopolysaccharide (LPS), promoting systemic inflammation and IR.
• Emerging Mechanisms: Recent research has identified other cellular processes that contribute to T2DM pathology. These include ferroptosis (an iron-dependent form of cell death), pyroptosis (an inflammatory form of programmed cell death), and dysregulated autophagy (the cellular process of degrading and recycling damaged components).

This intricate network of pathological processes highlights why T2DM is such a challenging condition to manage. It also suggests that therapies capable of acting on multiple pathways simultaneously may offer significant advantages, which links directly to the proposed mechanisms of the TCM therapies evaluated next.

3.0 Evidence Review: Traditional Chinese Herbal Medicine in T2DM Management

Traditional Chinese Herbal Medicine operates on a principle of polypharmacology, utilizing complex formulas containing multiple active compounds to address the multifaceted nature of chronic diseases like T2DM. This approach allows for the simultaneous targeting of multiple pathological pathways, which aligns well with the modern understanding of the disease's complex pathophysiology. This section will first analyze the clinical evidence for the efficacy of TCM herbal formulas from a meta-analysis perspective and then delve into the proposed mechanisms of action of their key active components as identified through network pharmacology.

3.1 Clinical Efficacy of TCM Herbal Formulas: A Meta-Analysis Perspective

A recent meta-analysis encompassing 58 randomized controlled trials provides a quantitative summary of the clinical efficacy of TCM in T2DM management. The overall conclusion from this large body of evidence is that TCM, when used as a complementary therapy, demonstrates considerable effectiveness in improving glycemic control and modulating lipid profiles in patients with T2DM. The specific, quantified effects of TCM interventions compared to control groups on key clinical outcomes are presented below.

Clinical Outcome Indicator	Mean Difference (MD) vs. Control
Fasting Plasma Glucose (FPG)	-1.13 mmol/L (P < 0.00001)
Postprandial Plasma Glucose	-1.75 mmol/L (P < 0.00001)
Glycated Hemoglobin (HbA1c)	-0.75% (P < 0.00001)
Low-Density Lipoprotein Cholesterol (LDL-C)	-0.14 mmol/L (P = 0.0002)

3.2 High-Frequency Herbs and Proposed Mechanisms of Action

To understand the biological basis for these clinical effects, a network pharmacology analysis was performed on the formulas used in the reviewed studies. This analysis identified the six most frequently used herbs:

• Astragalus mongholicus (Huangqi)
• Codonopsis pilosula (Dangshen)
• Wolfiporia cocos (Fuling)
• Cornus officinalis (Shanzhuyu)
• Coptis chinensis (Huanglian)
• Alisma gramineum (Zexie)

The core finding of the network pharmacology analysis is that the therapeutic effects of these herbs are mediated by the synergistic action of multiple active components, such as quercetin, kaempferol, and stigmasterol. These compounds interact with a network of 32 core gene targets, influencing several key biological pathways implicated in T2DM. The primary signaling pathways identified as targets for these herbal components include:

• Insulin Signaling: Modulation of critical pathways such as the PI3K-AKT signaling pathway, which is central to glucose uptake and metabolism.
• Inflammatory Regulation: Downregulation of pro-inflammatory cascades like the TNF and IL-17 signaling pathways.
• Oxidative Stress Response: Activation of protective mechanisms such as the HIF-1 and NRF2 signaling axes, which help mitigate cellular damage from ROS.

The multi-target action of select active monomer compounds found within these herbs is further detailed in the table below, summarizing their reported therapeutic mechanisms.

Active Compound	Primary Source Herb(s)	Reported Therapeutic Mechanism(s)
Berberine	Coptis chinensis (Huanglian)	Improves insulin resistance, regulates lipid metabolism, suppresses pro-inflammatory factors, and activates the AMPK/NRF2 pathway to reduce oxidative stress.
Quercetin	Astragalus mongholicus (Huangqi), etc.	Combats oxidative stress by increasing antioxidant enzymes (GSH, SOD) and reducing ROS.
Puerarin	Pueraria montana (Gegen)	Protects pancreatic β-cells, improves insulin resistance, inhibits α-glucosidase, and reduces inflammation and oxidative stress.
Ginsenoside Rg1	Panax ginseng (Renshen)	Mitigates cellular damage by modulating the MAPK signaling pathway, reducing apoptosis-related proteins (Bax, Caspase-3), and regulating lipid metabolism.

Having reviewed the evidence for pharmacological interventions, the focus now shifts to physical interventions, introducing Traditional Chinese Exercise as another key pillar of TCM for diabetes management.

4.0 Evidence Review: Traditional Chinese Exercise (TCE) for T2DM Management

Physical activity is a cornerstone of T2DM management, widely recommended for its broad physiological benefits. Traditional Chinese Exercise (TCE) represents a distinct modality characterized by slow, continuous, and gentle movements integrated with principles of breath control and mindfulness. These exercises, such as Tai Chi and Baduanjin, are suitable for a broad population, including older adults and those with physical limitations, making them a highly accessible form of physical activity. This section will systematically review the clinical evidence for TCE in T2DM management based on a recent comprehensive scoping review.

4.1 Scope of Evidence and Intervention Characteristics

A recent scoping review synthesized the evidence from 78 Randomized Controlled Trials (RCTs) published between 2002 and 2024. This body of research indicates a growing scientific interest in the therapeutic potential of TCE for T2DM. The most commonly studied forms of TCE were:

• Baduanjin (n=39 studies)
• Tai Chi (n=23 studies)
• Qigong (n=9 studies)

A key finding from the review was the significant heterogeneity in the intervention protocols used across studies. This variability in exercise "dose" complicates direct comparisons and meta-analysis. The reported ranges were substantial:

• Frequency: 1 to 7 times per week
• Session Duration: 15 to 120 minutes
• Total Intervention Period: 2 weeks to 24 months (2 years)

4.2 Clinical Efficacy of TCE on T2DM Outcomes

Despite the methodological heterogeneity, the review of 78 RCTs indicates that TCE interventions have a positive effect on both primary and secondary clinical outcomes for patients with T2DM. The most consistently reported improvements were seen in glycemic indicators. The table below summarizes the frequency of positive findings for common clinical measures. It is important to interpret these as trends rather than definitive pooled outcomes, as the counts are not weighted for study quality or intervention intensity.

Reported Efficacy of TCE on Common Clinical Indicators

Outcome Indicator	Studies Reporting (n)	Studies with Positive Findings (n)	Main Findings/Trends
Fasting Plasma Glucose (FPG)	66	59	Significant reductions reported in most studies
Glycated Hemoglobin (HbA1c)	59	52	Significant reductions reported post-intervention
HOMA-IR	14	9	Improved insulin sensitivity reported in the majority
Triglycerides (TG)	39	33	Reductions in triglycerides frequently observed
Total Cholesterol (TC)	39	27	Reductions in total cholesterol frequently observed

4.3 Proposed Mechanisms of Action for TCE

The clinical benefits of TCE are thought to be mediated by a range of physiological mechanisms that align with the core pathophysiology of T2DM. The evidence suggests that TCE can influence metabolic health through the following pathways:

• Anti-inflammatory Effects: Studies have reported that TCE can significantly reduce levels of key pro-inflammatory markers, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and C-reactive protein (CRP). This helps to alleviate the chronic low-grade inflammation that drives insulin resistance, converging on the same inflammatory cascades (e.g., TNF signaling) targeted by active compounds in high-frequency TCM herbs.
• Antioxidant Effects: Evidence suggests TCE improves the body's antioxidant capacity. This is demonstrated by reported increases in the activity of crucial antioxidant enzymes like superoxide dismutase (SOD), which helps neutralize harmful reactive oxygen species.
• Improved Insulin Sensitivity: The gentle, aerobic nature of TCE may enhance insulin sensitivity and promote the uptake and utilization of glucose by peripheral tissues, thereby supporting glycemic homeostasis.
• Lipid Metabolism Regulation: As a form of moderate-intensity aerobic exercise, TCE can enhance lipolysis (the breakdown of fats) and accelerate the metabolism of triglycerides and cholesterol, helping to mitigate the metabolic disturbances associated with T2DM.

The collective findings on both herbal medicine and exercise demonstrate significant therapeutic potential. However, to translate these findings into reliable clinical practice, a critical evaluation of the overall quality of this evidence is essential.

5.0 Synthesis and Methodological Critique of the Evidence Base

While the preceding sections demonstrate the considerable potential of TCM interventions for managing T2DM, a rigorous, evidence-based assessment requires a critical evaluation of the research methodologies employed. Although promising, the current body of literature is constrained by several significant limitations that temper definitive conclusions and highlight the preliminary nature of the evidence. This section synthesizes the major methodological issues identified across the reviewed literature.

1. High Heterogeneity in Interventions: There is a pronounced lack of standardization across studies. For herbal medicine, formulas and dosages vary widely. For Traditional Chinese Exercise, prescriptions differ substantially in frequency (1-7 times/week), duration (15-120 minutes/session), intensity, and total intervention period (2 weeks to 24 months). This high degree of heterogeneity undermines the comparability of trial results and makes it difficult to establish optimal therapeutic protocols.
2. Suboptimal Study Quality and Reporting: Many of the reviewed studies suffer from methodological weaknesses. Common issues include inadequate reporting on the methods used for randomization and allocation concealment, which introduces a risk of selection bias. Furthermore, a general lack of blinding for participants and outcome assessors was noted in both the herbal medicine and TCE reviews, increasing the potential for performance and detection bias. Adherence to rigorous trial reporting guidelines is often lacking.
3. Small Sample Sizes: A significant portion of the evidence base is derived from trials with small sample sizes. For example, many TCE studies enrolled fewer than 30 participants per group. Small samples reduce the statistical power of a study, making it difficult to detect true effects and increasing the risk that findings are due to chance. This limits the reliability and robustness of the conclusions drawn from individual trials.
4. Limited and Inconsistent Outcome Measures: While most studies consistently measured primary glycemic outcomes like FPG and HbA1c, fewer investigated important mechanistic endpoints such as inflammatory markers, oxidative stress indices, or gut microbiota composition. Furthermore, the findings for secondary outcomes (e.g., lipid profiles, blood pressure, vascular function) were often inconsistent or inconclusive across studies, weakening the overall evidence for these effects.
5. Insufficient Safety and Follow-up Data: The reporting of adverse events was profoundly insufficient; only 5 of 78 TCE studies addressed safety, and this likely reflects underreporting rather than a true absence of risk. Similarly, very few studies included long-term follow-up, which hinders a comprehensive evaluation of the sustained efficacy and long-term safety of these interventions.
6. Geographic and Population Concentration: The vast majority of the reviewed studies were conducted in mainland China. This geographic concentration constrains the external validity of the findings and raises questions about their generalizability to other ethnic, cultural, and healthcare contexts.

These collective methodological weaknesses mean that the current evidence, while encouraging, should be considered preliminary and exploratory. This sets a clear stage for discussing the immediate clinical implications and defining the critical research needs for the future.

6.0 Clinical Implications and Future Research Directions

Translating the reviewed evidence and its limitations into actionable insights for clinicians and researchers is a crucial final step. While the current data is not robust enough to establish definitive clinical practice guidelines, it offers preliminary guidance for patient care and clearly illuminates the path forward for future investigation. Addressing the identified gaps in the evidence base is essential for realizing the full potential of these therapies.

6.1 Implications for Clinical Practice

• Role as a Complementary Strategy: Based on the available evidence, TCE and certain well-studied TCM herbal formulas can be considered as valuable complementary strategies in the management of T2DM. Clinicians should frame this as a cautious recommendation, emphasizing their use alongside, not in place of, established conventional care, including lifestyle modification and pharmacotherapy.
• Benefits Beyond Glycemic Control: A key advantage of these interventions, particularly TCE, is their potential to offer benefits beyond metabolic regulation. Reported improvements in neuromuscular function, flexibility, quality of life, and psychological well-being (e.g., reduced anxiety and depression) are highly valuable to patients and contribute to a more holistic approach to care.
• Importance of an Individualized Approach: Given the significant heterogeneity in both the interventions studied and patient responses, a "one-size-fits-all" approach is inappropriate. Clinicians should work with patients to select interventions that align with their physical capabilities, preferences, and cultural backgrounds, while closely monitoring their response.

6.2 Recommendations for Future Research

To build a more reliable evidence base, the research community must address the methodological shortcomings of past studies. The following agenda is proposed for future research:

• High-Quality RCTs: There is an urgent need for large-scale, multicenter, and methodologically rigorous Randomized Controlled Trials (RCTs). These trials must be adequately powered, employ robust randomization and blinding procedures, and adhere to international reporting standards to ensure transparency and minimize bias.
• Standardized Protocols: To overcome the issue of heterogeneity, future research should focus on developing and testing standardized prescriptions for both TCE (specifying type, frequency, duration, and intensity) and herbal formulas. This will ensure consistency across studies and facilitate meaningful comparisons and meta-analyses.
• Comprehensive Outcome Assessment: Future trials should move beyond a narrow focus on glycemic markers. A broader range of validated outcomes should be included, such as mechanistic endpoints (e.g., inflammatory markers, gut microbiota profiles, oxidative stress indices), patient-reported outcomes (e.g., quality of life, symptom burden), and comprehensive, long-term safety and adverse event data.
• Cross-Cultural and Diverse Population Studies: To establish broader applicability and external validity, research must be expanded to non-Chinese populations. Studies conducted in diverse ethnic, cultural, and healthcare settings are essential to confirm the effectiveness of these interventions globally.
• Head-to-Head Comparative Studies: Well-designed studies are needed to directly compare the effectiveness of different TCM interventions (e.g., Tai Chi vs. Baduanjin) or to compare TCM interventions against standard-of-care lifestyle interventions (e.g., conventional exercise programs). This will help clarify their relative benefits and place in the therapeutic hierarchy.

Addressing these research priorities will be essential for validating the promising but preliminary findings and integrating these therapies into mainstream, evidence-based clinical care for T2DM.

7.0 Conclusion

This comprehensive review of the literature indicates that both Traditional Chinese Herbal Medicine and Traditional Chinese Exercise show considerable promise as complementary therapies for improving key metabolic parameters in patients with Type 2 Diabetes Mellitus. Evidence from meta-analyses and network pharmacology suggests that TCM herbs can effectively lower blood glucose and lipids by targeting multiple pathological pathways, including inflammation and oxidative stress. Similarly, a large body of evidence from randomized controlled trials supports the use of TCE, such as Tai Chi and Baduanjin, for improving glycemic control and offering holistic benefits to patient well-being.

However, a primary caveat must be emphasized: the current body of evidence is constrained by significant methodological limitations. Pervasive issues, including high heterogeneity in intervention protocols, suboptimal study quality, small sample sizes, and insufficient safety and follow-up data, prevent the formulation of definitive clinical guidelines. Therefore, while the existing findings are encouraging, they must be interpreted with caution.

High-quality, methodologically rigorous clinical trials are urgently needed to validate these preliminary findings. Future research must focus on standardized interventions, comprehensive outcome assessments, and diverse populations to provide the robust evidence base required to support the standardized clinical application and integration of TCM interventions into global T2DM management.

8.0 References

Wang M, Yang Q, Li Y, et al. Therapeutic potential of traditional Chinese medicine and mechanisms for the treatment of type 2 diabetes mellitus. Chin Med. 2025;20(1):157. Published 2025 Oct 4.

Niu H, Zhou M, Zhou L, et al. Mechanisms of acupuncture in the treatment of type 2 diabetes mellitus: insights from the regulation of the gut microecology. Front Immunol. 2025;16:1682521. Published 2025 Nov 20.

Ren H, Zhang N, Li Y, et al. Complementary intervention effects of traditional Chinese exercise therapies on T2DM: A scoping review. Medicine (Baltimore). 2025;104(48):e46243.

Tang S, Lin J, Li G, Guo H, Liu C, Wu F. Evaluating efficacy and mechanism of traditional Chinese medicine in diabetes treatment: a meta-analysis and network pharmacology study. Front Endocrinol (Lausanne). 2025;16:1605091. Published 2025 Oct 7.

Lara-Castor L, O'Hearn M, Cudhea F, et al. Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries. Nat Med. 2025;31(2):552-564.